Estimate Recalculated Sep 9, 2024 12:27AM EST
Gregory T. Mayes, does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include UNIGENE LABORATORIES INC, AVEO PHARMACEUTICALS INC, Advaxis, Inc., ONCOSEC MEDICAL Inc, DENDREON CORP, and IMCLONE SYSTEMS INC.
Gregory T. Mayes,'s CIK is 0001424630
2015 was Gregory T. Mayes,'s most active year for acquiring shares with 14 total transactions. Gregory T. Mayes,'s most active month to acquire stocks was the month of December. 2014 was Gregory T. Mayes,'s most active year for disposing of shares, totalling 14 transactions. Gregory T. Mayes,'s most active month to dispose stocks was the month of December. 2016 saw Gregory T. Mayes, paying a total of $28,347.24 for 72,430 shares, this is the most they've acquired in one year. In 2015 Gregory T. Mayes, cashed out on 19,645 shares for a total of $228,975.19, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!